BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25366709)

  • 1. Functional imaging in pre-motor Parkinson's disease.
    Arnaldi D; Morbelli S; Picco A; Ferrara M; Buschiazzo A; Famà F; De Carli F; Nobili F
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):366-75. PubMed ID: 25366709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
    Stiasny-Kolster K; Doerr Y; Möller JC; Höffken H; Behr TM; Oertel WH; Mayer G
    Brain; 2005 Jan; 128(Pt 1):126-37. PubMed ID: 15548552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
    Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
    Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease.
    Meles SK; Renken RJ; Janzen A; Vadasz D; Pagani M; Arnaldi D; Morbelli S; Nobili F; Mayer G; Leenders KL; Oertel WH;
    J Nucl Med; 2018 Sep; 59(9):1437-1444. PubMed ID: 29476004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implication of REM sleep behavior disorder in Parkinson's disease.
    Kim YE; Jeon BS
    J Parkinsons Dis; 2014; 4(2):237-44. PubMed ID: 24613864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain Glucose Metabolism Heterogeneity in Idiopathic REM Sleep Behavior Disorder and in Parkinson's Disease.
    Arnaldi D; Meles SK; Giuliani A; Morbelli S; Renken RJ; Janzen A; Mayer G; Jonsson C; Oertel WH; Nobili F; Leenders KL; Pagani M;
    J Parkinsons Dis; 2019; 9(1):229-239. PubMed ID: 30741687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?
    Arnaldi D; De Carli F; Picco A; Ferrara M; Accardo J; Bossert I; Famà F; Girtler N; Morbelli S; Sambuceti G; Nobili F
    Neurobiol Aging; 2015 Dec; 36(12):3300-3305. PubMed ID: 26410306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease.
    Kang SH; Lee HM; Seo WK; Kim JH; Koh SB
    J Neurol Sci; 2016 Sep; 368():374-8. PubMed ID: 27538667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between (123)I-MIBG scintigrams and REM sleep behavior disorder in Parkinson's disease.
    Nomura T; Inoue Y; Högl B; Uemura Y; Kitayama M; Abe T; Miyoshi H; Nakashima K
    Parkinsonism Relat Disord; 2010 Dec; 16(10):683-5. PubMed ID: 20846893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging of rapid eye movement sleep behavior disorder: transcranial ultrasound, single-photon emission computed tomography, and positron emission tomography scan data.
    Miyamoto M; Miyamoto T
    Sleep Med; 2013 Aug; 14(8):739-43. PubMed ID: 23648146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
    Pagano G; De Micco R; Yousaf T; Wilson H; Chandra A; Politis M
    Neurology; 2018 Sep; 91(10):e894-e905. PubMed ID: 30089615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sleep behavior disorder (RBD) in synucleionopaties].
    Glas Srp Akad Nauka Med; 2009; (50):7-15. PubMed ID: 20666111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study.
    Liguori C; Ruffini R; Olivola E; Chiaravalloti A; Izzi F; Stefani A; Pierantozzi M; Mercuri NB; Modugno N; Centonze D; Schillaci O; Placidi F
    Parkinsonism Relat Disord; 2019 Jul; 64():97-105. PubMed ID: 30930059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and timeline of nonmotor symptoms in idiopathic rapid eye movement sleep behavior disorder.
    Aguirre-Mardones C; Iranzo A; Vilas D; Serradell M; Gaig C; Santamaría J; Tolosa E
    J Neurol; 2015 Jun; 262(6):1568-78. PubMed ID: 25929658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD.
    Arnaldi D; Morbelli S; Brugnolo A; Girtler N; Picco A; Ferrara M; Accardo J; Buschiazzo A; de Carli F; Pagani M; Nobili F
    Parkinsonism Relat Disord; 2016 Aug; 29():47-53. PubMed ID: 27264343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder.
    Rupprecht S; Walther B; Gudziol H; Steenbeck J; Freesmeyer M; Witte OW; Günther A; Schwab M
    Sleep Med; 2013 Nov; 14(11):1064-70. PubMed ID: 23948220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.
    Barone DA; Henchcliffe C
    Clin Neurophysiol; 2018 Aug; 129(8):1551-1564. PubMed ID: 29883833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
    Meles SK; Oertel WH; Leenders KL
    Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tract-Based Spatial Statistics Reveal Lower White Matter Integrity Specific to Idiopathic Rapid Eye Movement Sleep Behavior Disorder as a Proxy for Prodromal Parkinson's Disease.
    Ohlhauser L; Smart CM; Gawryluk JR
    J Parkinsons Dis; 2019; 9(4):723-731. PubMed ID: 31498130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.